Health care reform is supposed to do three noble things: expand access, improve outcomes, and stop the financial bleeding. It is not supposed to become a coupon book for pseudoscience wearing a stethoscope-shaped nametag. Yet every time lawmakers revisit health policy, a familiar sideshow appears: lobbying efforts to force coverage, legitimacy, or taxpayer support for therapies that either lack convincing evidence or rest on ideas that would make a physics professor spill their coffee.
That is why the call to join the Center for Inquiry, or CFI, in opposing funding mandates for quackery in health care reform still matters. The issue is bigger than one bill, one political season, or one especially ambitious bottle of homeopathic tablets. It is about whether public policy should reward treatments because they are popular, politically connected, or packaged as “integrative,” or because they have been tested and shown to help real patients in the real world.
That distinction is everything. In medicine, words like natural, holistic, and traditional may sound warm and reassuring. But insurance law, Medicare rules, and taxpayer budgets should not be driven by vibes. They should be driven by evidence. If health reform starts funding weakly supported or plainly implausible treatments by mandate, the result is not compassion. It is waste dressed up as wellness.
Why This Fight Exists in the First Place
CFI has spent years challenging medical pseudoscience and consumer fraud, including homeopathy, deceptive health claims, and attempts to give unsupported therapies a policy shortcut. During earlier reform debates, CFI objected when lawmakers and advocates flirted with ideas that could direct public money or policy recognition toward practices such as Therapeutic Touch, a method built around the claim that practitioners can manipulate a human energy field without actual touch. If that sentence made your eyebrow twitch, congratulations: your scientific instincts are working.
The broader concern was not merely that one odd therapy might sneak into a hearing room. It was that health care reform could normalize a dangerous habit: treating all licensed or loudly promoted health approaches as if they deserve equal footing. They do not. A state license is not a magic wand. A wellness brochure is not a randomized trial. A treatment becomes worthy of coverage when evidence shows that the benefits outweigh the harms and costs.
That principle sounds obvious, but policy debates often blur it. Once lawmakers use broad language about “provider nondiscrimination” or “integrative access,” unsupported services can hitch a ride beside legitimate care. Suddenly the discussion is no longer about scientific merit. It becomes a political scrum over fairness, professional turf, and patient choice. Those issues matter, but they cannot replace proof.
The Problem With Funding Mandates
Mandates turn weak evidence into guaranteed spending
A funding mandate does more than permit insurers or public programs to cover a service. It pressures them to pay for it whether or not the evidence is strong. That is the key problem. Health reform is always sold as a serious exercise in priorities. Money is limited. Premiums are painful. Public budgets are tighter than airport legroom. If lawmakers force coverage of unproven or implausible treatments, they are choosing to divert resources away from interventions with stronger evidence.
That diversion carries a real opportunity cost. Every dollar spent on pseudoscientific care is a dollar not spent on primary care access, vaccination outreach, chronic disease management, mental health treatment, maternal care, or evidence-based pain services. Health policy should be hard-headed about tradeoffs. Quackery thrives when the adults in the room pretend tradeoffs do not exist.
Mandates can create false legitimacy
Coverage sends a message. Patients often assume that if insurance pays for something, it must be effective. That assumption is understandable and often wrong. When unsupported therapies receive mandated coverage, the public can easily interpret reimbursement as endorsement. The therapy starts to look medically validated when, in reality, it may only be politically validated.
That is especially troubling in categories where marketing already outruns evidence. The FDA has repeatedly warned that products labeled as homeopathic may not meet modern standards for safety, effectiveness, and quality. The FTC has also made clear that health-related claims for over-the-counter homeopathic drugs should meet the same truth-and-evidence standards as other products. In plain English: if a product says it helps, the seller needs real scientific support, not fairy dust and typography.
Mandates can delay effective treatment
Not every alternative therapy is equally risky. A relaxation technique used alongside standard care is very different from a bogus cancer cure sold as a replacement for oncology. Still, even seemingly low-drama pseudoscience can cause harm by delaying proper diagnosis, encouraging magical thinking, or draining a patient’s time and money. The National Cancer Institute draws a useful line here: some complementary approaches may help with symptoms such as stress, discomfort, or quality of life, but they are not substitutes for standard treatment. That distinction should be tattooed on the forehead of every policymaker drafting coverage rules.
What the Evidence Actually Shows
The evidence landscape for complementary and alternative medicine is mixed, and pretending otherwise helps no one. Some practices associated with “integrative health” may offer limited benefit for specific symptoms or patient populations. Others have little convincing support. Some are biologically plausible and worth studying. Others are built on premises so implausible that they would need spectacular evidence to overcome the scientific red flags.
NCCIH itself has moved toward a more evidence-focused posture over time, emphasizing that complementary approaches should be studied rigorously and, when supported, integrated rather than used as alternatives to conventional care. That shift is important. It reflects an uncomfortable truth: calling something “integrative” does not automatically upgrade the evidence. A treatment does not become more credible just because it now comes with softer lighting and a nicer brochure.
Take homeopathy. NCCIH explains that homeopathy is based on theories developed more than two centuries ago, including the notion that substances causing symptoms in healthy people can treat similar symptoms in sick people and that extreme dilution somehow increases healing power. Modern chemistry has entered the chat, looked around, and quietly backed out. Federal agencies have repeatedly warned consumers that homeopathic products are not FDA-approved for any use and may pose risks or offer no meaningful benefit.
Take Therapeutic Touch. The famous 1998 JAMA study by Emily Rosa and colleagues tested whether practitioners could actually detect the “human energy field” they claimed to manipulate. They could not do so better than chance. That finding landed like a brick because it tested the foundational claim, not just a vague patient-reported feeling afterward. If a therapy depends on sensing a force that practitioners cannot reliably sense under blinded conditions, policymakers should not be asked to subsidize it with a straight face.
Meanwhile, data on spending show why this debate is not trivial. Americans have spent tens of billions of dollars out of pocket on complementary health approaches, and a substantial share goes to practitioner visits and products outside standard medical care. That means pseudoscientific and weakly supported care is not some tiny side hustle in the wellness economy. It is a major commercial ecosystem. Once public coverage mandates enter the picture, private demand can become institutionalized spending.
Where Health Reform Often Goes Off Course
It confuses patient-centered care with evidence-free care
Patient-centered care matters. Respect for patient values matters. Listening matters. But none of those ideals require the health system to pay for treatments that do not work. Good reform should make medicine more humane without making it more gullible. The ethical standard is not “give every patient whatever sounds appealing.” It is “give patients honest information, respect their autonomy, and recommend the options with the best evidence.”
That is also the sensible reading of fairness. If conventional medicine is expected to justify treatments through trials, outcome data, and ongoing review, alternative therapies should meet the same bar. The AMA’s ethics literature has made versions of this point for years: fairness means applying rigorous standards consistently, not creating a scientific VIP lounge for fashionable pseudoscience.
It uses broad legal language that can be stretched later
Section 2706 of the Affordable Care Act, the provider nondiscrimination provision, is a good example of how apparently simple language can create lasting policy controversy. CMS guidance makes clear that the provision does not force plans to contract with every willing provider, but critics have argued that such language can still be used to push broader acceptance of providers or services that lack strong evidence. In other words, once the door is cracked open, lobbyists bring snacks and move in.
It underestimates fraud, waste, and abuse
Health reform is always vulnerable to the same enemy trio: fraud, waste, and abuse. HHS OIG continues to stress the importance of policing improper payments and ensuring public dollars are spent appropriately. Pseudoscientific care complicates that mission because it may live in a gray zone between legal reimbursement and poor medical value. Even when a claim is not classic fraud, it may still be terrible policy. Taxpayers should not have to fund a national shrug.
What Smarter Reform Would Look Like
If lawmakers genuinely want better reform, they should adopt a few brutally simple rules.
First, coverage should follow evidence, not branding
Services should be evaluated on clinical outcomes, safety, comparative effectiveness, and cost-effectiveness. If a therapy helps, great. Cover it because it helps. If it fails, do not rescue it with semantic tricks like “whole person,” “energy balancing,” or “ancient wisdom.” The adjective should not do more work than the data.
Second, complementary should never mean replacement for effective care
Supportive therapies that reduce stress, improve comfort, or help patients cope may have a place when clearly framed as adjuncts. But health reform must never imply that symptom relief methods and disease-modifying treatments are interchangeable. They are not cousins. They are barely acquaintances.
Third, public communication should be brutally honest
Patients deserve plain language about what is known, what is uncertain, and what is unsupported. Not every health claim deserves diplomatic phrasing. Sometimes the most ethical communication is also the least fancy: “There is not good evidence this works.”
Fourth, reform should invest in what is already underfunded and proven
Preventive care, primary care, mental health integration, addiction treatment, maternal health, and chronic disease support do not need pseudoscientific company to be valuable. They need stable funding, better access, and policy follow-through. Real reform has plenty to do before it starts underwriting magic-adjacent nonsense.
Experiences That Show Why This Debate Feels So Personal
One reason this issue refuses to stay abstract is that almost everyone has a story. Maybe it is the friend who was offered a pricey “natural” program for fatigue before anyone checked for anemia, sleep apnea, or depression. Maybe it is the parent who walked into a pharmacy, saw homeopathic products lined up beside evidence-based medicine, and reasonably assumed both had cleared the same scientific bar. Maybe it is the patient with chronic pain who just wanted relief and got bounced between expensive wellness promises before finally reaching a clinician who offered a careful, evidence-based plan.
These experiences are not rare. They are the emotional fuel that keeps quackery alive. When people feel dismissed, rushed, scared, or chronically uncomfortable, they become more vulnerable to treatments that promise certainty, gentleness, or secret knowledge. Pseudoscience is often less about gullibility than desperation with a nice label on it. That is why the solution cannot be sneering at patients. The solution is building a health system that is compassionate and scientifically honest.
Clinicians also have experiences that shape their skepticism. Many have seen patients arrive after months of spending money on supplements, energy therapies, detox packages, or mystical diagnostics that produced glossy charts and very little help. The patient is poorer, discouraged, and sometimes sicker. The clinician then has to do two jobs at once: treat the actual medical problem and gently unwind the false story the patient was sold. That is hard work, and it gets harder when public policy gives weak therapies an aura of official approval.
There is also the quiet frustration of mixed messaging. A patient may hear from one institution that evidence matters, from another that “all healing traditions are valid,” and from a third that the truth is somewhere in the middle, preferably after a copay. It is no wonder people get confused. Health care already has enough complexity without adding policy-sponsored ambiguity about whether water memory, invisible energy fields, or theatrical dilution deserve a seat at the reimbursement table.
Families feel the strain too. When a loved one has cancer, chronic pain, dementia, autoimmune disease, or severe anxiety, everyone becomes vulnerable to hope marketed as treatment. Relatives want to help. Friends send links. Social media becomes a carnival of miracle stories. In that moment, clear policy boundaries matter. A system that says, “We will fund what is supported and warn against what is not,” protects patients when they are least able to sort evidence from salesmanship.
Even the seemingly small experiences matter. The awkward conversation at a dinner table. The nurse who rolls their eyes at a fake remedy but cannot say much because the institution wants to sound inclusive. The insurer that covers a trendy intervention while making evidence-based mental health care feel like a scavenger hunt. The patient who thinks, “If this is covered, it must be legitimate.” Those tiny moments accumulate. They shape public trust.
That is why opposing quackery mandates is not cold or anti-patient. It is the opposite. It is a defense of patients against confusion, false hope, and misallocated resources. It is a demand that health care reform take suffering seriously enough to insist on honesty. The public deserves empathy, but it also deserves evidence. When reform forgets that, it stops being reform and starts becoming performance art with billing codes.
Conclusion
Joining CFI in opposing funding mandates for quackery in health care reform is ultimately a vote for clarity. Health policy should not pretend all medical claims are created equal. It should not launder unsupported therapies through coverage rules, professional politics, or feel-good language. And it should not ask taxpayers or premium payers to underwrite treatments that have not earned their place through evidence.
Real reform is difficult enough without adding pseudoscience to the shopping cart. The smartest path forward is also the simplest: study rigorously, communicate honestly, cover what works, and leave quackery to the museum gift shop where it belongs.
Note: Clean HTML body only, ready for web publishing.
